Third Arc Bio Emerges with $165 Million to Innovate in Solid Tumors and Autoimmune Diseases A team of Johnson & Johnson veterans launched Third Arc Bio with $165 million in [….]
IndyGeneUS AI and the Blockchain-Secured Genomic Data Marketplace IndyGeneUS AI, which is harnessing the power of data mining and artificial intelligence to expedite the development and manufacturing of targeted therapeutics, [….]
Johnson & Johnson hopes to bridge health insurance divide with its Health Equity Innovation Challenge. The challenge aims to support potential innovative solutions from local entrepreneurs, innovators and local community-based organizations.
